CPIX
Price:
$1.12
Market Cap:
$15.79M
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibat...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2009-08-11
Stock Exchange
NASDAQ
Ticker
CPIX
According to Cumberland Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.02M. This represents a change of -23.37% compared to the average of 26.12M of the last 4 quarters.
The mean historical Enterprise Value of Cumberland Pharmaceuticals Inc. over the last ten years is 56.85M. The current 20.02M Enterprise Value has changed 3.42% with respect to the historical average. Over the past ten years (40 quarters), CPIX's Enterprise Value was at its highest in in the June 2019 quarter at 98.40M. The Enterprise Value was at its lowest in in the June 2023 quarter at 21.86M.
Average
56.85M
Median
57.41M
Minimum
25.70M
Maximum
85.97M
Discovering the peaks and valleys of Cumberland Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 58.23%
Maximum Annual Enterprise Value = 85.97M
Minimum Annual Increase = -48.95%
Minimum Annual Enterprise Value = 25.70M
Year | Enterprise Value | Change |
---|---|---|
2023 | 25.70M | -24.34% |
2022 | 33.97M | -42.06% |
2021 | 58.62M | 58.23% |
2020 | 37.05M | -48.95% |
2019 | 72.57M | -15.58% |
2018 | 85.97M | 5.48% |
2017 | 81.50M | 45.05% |
2016 | 56.19M | 9.26% |
2015 | 51.42M | -21.48% |
2014 | 65.49M | 24.00% |
The current Enterprise Value of Cumberland Pharmaceuticals Inc. (CPIX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
39.43M
5-year avg
45.58M
10-year avg
56.85M
Cumberland Pharmaceuticals Inc.’s Enterprise Value is greater than Eagle Pharmaceuticals, Inc. (14.27M), less than Regencell Bioscience Holdings Limited (102.37M), less than Procaps Group S.A. (473.75M), less than Incannex Healthcare Limited (40.21M), greater than Petros Pharmaceuticals, Inc. (3.57M), greater than Evoke Pharma, Inc. (573.94K), greater than Agile Therapeutics, Inc. (7.87M), greater than PainReform Ltd. (-1732320.00), greater than Shuttle Pharmaceuticals Holdings, Inc. (5.38M), less than Mallinckrodt plc (2.62B), less than Organogenesis Holdings Inc. (389.07M), greater than Lucy Scientific Discovery Inc. (2.06M), less than Alimera Sciences, Inc. (362.58M), less than Lifecore Biomedical, Inc. (338.76M), less than Kamada Ltd. (292.44M), less than Ironwood Pharmaceuticals, Inc. (1.20B), greater than Biofrontera Inc. (3.10M), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Akanda Corp. (-3520199.00), greater than China Pharma Holdings, Inc. (7.72M),
Company | Enterprise Value | Market cap |
---|---|---|
14.27M | $7.13M | |
102.37M | $105.27M | |
473.75M | $201.39M | |
40.21M | $45.69M | |
3.57M | $3.40M | |
573.94K | $4.75M | |
7.87M | $10.43M | |
-1732320.00 | $1.00M | |
5.38M | $4.92M | |
2.62B | $4.52M | |
389.07M | $368.56M | |
2.06M | $906.91K | |
362.58M | $301.29M | |
338.76M | $216.36M | |
292.44M | $340.28M | |
1.20B | $669.31M | |
3.10M | $6.04M | |
-10475955.00 | $4.35M | |
-3520199.00 | $2.14M | |
7.72M | $4.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cumberland Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cumberland Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cumberland Pharmaceuticals Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cumberland Pharmaceuticals Inc. (CPIX)?
What is the 3-year average Enterprise Value for Cumberland Pharmaceuticals Inc. (CPIX)?
What is the 5-year average Enterprise Value for Cumberland Pharmaceuticals Inc. (CPIX)?
How does the current Enterprise Value for Cumberland Pharmaceuticals Inc. (CPIX) compare to its historical average?